Lipocine Inc. (LPCN) › EPS (Diluted)Lipocine Inc. (LPCN) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2012: $0.852013: $-1.442014: $-1.602015: $-1.112016: $-1.042017: $-1.052018: $-0.552019: $-0.502020: $-0.382021: $-0.012022: $-2.152023: $-3.142025: $-1.69$-1.692012EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-1.69—2023$-3.14-46.0%2022$-2.15-21400.0%2021$-0.01+97.4%2020$-0.38+24.0%2019$-0.50+9.1%2018$-0.55+47.6%2017$-1.05-1.0%2016$-1.04+6.3%2015$-1.11+30.6%2014$-1.60-11.1%2013$-1.44-269.4%2012$0.85—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share